Javelin Pharmaceuticals

NCT00548678

Phase 1, Completed, 2007, 30 people, 24 Oct 2007, clinicaltrials.gov

NCT00390312

Phase 2, Completed, 2001, 225 people, 19 Oct 2006, clinicaltrials.gov

NCT00390039

Phase 3, Completed, 2006, 256 people, 19 Oct 2006, clinicaltrials.gov

NCT00388011

Phase 2, Completed, 2005, 187 people, 13 Oct 2006, clinicaltrials.gov